This topic contains a solution. Click here to go to the answer

Author Question: In 1999, the United States began using the ________ for coding and classification of mortality data. ... (Read 66 times)

tuffie

  • Hero Member
  • *****
  • Posts: 534
In 1999, the United States began using the ________ for coding and classification of mortality data.
 
  a. Bertillon Classification
  b. ICD-9-CM
  c. ICD-10
  d. ICD-10-CM

Question 2

Dr. Smith is in Labadie, Missouri and has a conference call with Dr. Baldwin, who is in Clearwater, Florida, at 12 P.M. Eastern time. What time will Dr. Smith need to be on the conference call?
 
  a. 10 A.M.
  b. 11 A.M.
  c. 12 P.M.
  d. 1 P.M.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kimmy

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

d

Answer to Question 2

b




tuffie

  • Member
  • Posts: 534
Reply 2 on: Jun 25, 2018
:D TYSM


bblaney

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library